Do aromatase inhibitors increase cardiovascular risk? Piecing together the evidence
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference22 articles.
1. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials;Dowsett;Lancet,2015
2. The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer;Abdel-Qadir;Eur J Cancer,2016
3. The central role of the propensity score in observational studies for causal effects;Rosenbaum;Biometrika,1983
4. Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial;Mouridsen;J Clin Oncol,2007
5. Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials;Cuppone;Cancer,2008
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association of polymorphisms in the sex hormone genes with the presence and severity of coronary artery disease;Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology;2022-01-06
2. CYP19A1 polymorphisms associated with coronary artery disease and circulating sex hormone levels in a Chinese population;Oncotarget;2017-10-07
3. Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial;The Lancet Oncology;2017-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3